MJardin Group, Inc. Share Price Canadian Securities Exchange
Equities
MJAR
CA60689X1096
Pharmaceuticals
Sales 2019 | 26.7M 36.54M 2.23B | Sales 2020 | 11.44M 15.65M 954M | Capitalization | 3.41M 4.67M 285M |
---|---|---|---|---|---|
Net income 2019 | -267M -365M -22.28B | Net income 2020 | -34M -46.53M -2.84B | EV / Sales 2019 | 5.55 x |
Net Debt 2019 | 134M 183M 11.14B | Net Debt 2020 | 164M 224M 13.67B | EV / Sales 2020 | 14.6 x |
P/E ratio 2019 |
-0.06
x | P/E ratio 2020 |
-0.1
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 92.27% |
Managers | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 26/21/26 |
Edward Jonasson
DFI | Director of Finance/CFO | 55 | 01/19/01 |
Patrick Witcher
BRD | Director/Board Member | - | 07/19/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anthony Dutton
CEO | Chief Executive Officer | 66 | 26/21/26 |
Blair Jordan
BRD | Director/Board Member | 55 | 26/21/26 |
James Lowe
BRD | Director/Board Member | - | 06/19/06 |
1st Jan change | Capi. | |
---|---|---|
+43.25% | 6.3B | |
-15.08% | 4.44B | |
-6.70% | 3.27B | |
+5.47% | 3.16B | |
+0.76% | 2.58B | |
+47.75% | 1.96B | |
-5.08% | 1.73B | |
+2.05% | 1.68B | |
-7.08% | 1.63B |